EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieOpen Access · CC BY 4.0

Radiofrequency Echographic Multi-Spectrometry for bone health assessment in prostate cancer patients receiving Androgen deprivation therapy: A prospective comparative observational study

Radiofrequenz-Echographische Multi-Spektrometrie zur Beurteilung der Knochengesundheit bei Prostatakrebspatienten unter Androgendeprivationstherapie: prospektive vergleichende Beobachtungsstudie

Manuela Montatore, Riccardo Guglielmi, Amanda Isaac, Maria Grazia Capasso, Antonio Corvasce, Federica Masino, Giuseppe Guglielmi

Aging Clinical and Experimental Research · 04.08.2026 · 38 (1)

DOI: 10.1007/s40520-026-03467-4 ↗

Auf einen Blick

Bei 83 Männern mit Prostatakrebs unter Androgendeprivationstherapie war die per REMS gemessene Knochendichte an Lendenwirbelsäule und Schenkelhals niedriger als bei 60 Kontrollen.

Fragestellung

Unterscheidet sich die per REMS bestimmte Knochenmineraldichte an Lendenwirbelsäule und Schenkelhals bei Männern mit Prostatakrebs unter Androgendeprivationstherapie von gesunden Kontrollen?

Methode

Querschnittstudie mit 143 kaukasischen Männern zwischen Oktober 2023 und Oktober 2024; REMS-Messungen an Lendenwirbelsäule und Schenkelhals; Gruppenvergleich mit unpaired t-Test.

Ergebnisse

83 Patienten unter ADT und 60 Kontrollen. Lendenwirbelsäule: 0,885 ± 0,08 vs. 0,945 ± 0,11 g/cm²; p = 0,007; 6,3 % Unterschied. Schenkelhals: 0,691 ± 0,08 vs. 0,715 ± 0,10 g/cm²; p = 0,01; 3,4 % Unterschied.

Einschränkungen

Longitudinale Nachbeobachtung läuft noch; dadurch ist die zeitliche Beziehung zwischen ADT und Knochenverlust offen.

Schlussfolgerung der Autor:innen

Die Befunde passen zu den bekannten skeletalen Effekten der ADT und unterstützen REMS als strahlungsfreies Verfahren zur Identifikation verringerter axialer Knochendichte.

Kernaussagen

  • REMS zeigte niedrigere BMD unter ADT an LWS und Schenkelhals
  • LWS: 0,885 vs. 0,945 g/cm²; p = 0,007
  • Schenkelhals: 0,691 vs. 0,715 g/cm²; p = 0,01

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Aging Clinical and Experimental Research, online erschienen am 04.08.2026. Verfasst von Manuela Montatore und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Viale L. Pinto 1, Foggia, 71121, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Density, Androgen Antagonists. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università di Foggia.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgen deprivation therapy (ADT), used in selected patients with prostate cancer (PCa), is associated with accelerated bone loss and increased fragility fracture risk. Radiofrequency Echographic Multi-Spectrometry (REMS) is a non-ionizing ultrasound-based technique for axial bone mineral density (BMD) assessment.

Aim

To evaluate REMS-derived BMD at the lumbar spine and femoral neck in men with PCa receiving ADT and in age- and body mass index-matched healthy controls.

Methods

In this cross-sectional study, 143 Caucasian men were enrolled between October 2023 and October 2024: 83 patients with histologically confirmed PCa receiving ADT for at least 6 months and 60 healthy controls. REMS scans were performed at the lumbar spine and femoral neck. Between-group differences in BMD, T-score, and Z-score were assessed using an unpaired t -test.

Results

Compared with controls, patients receiving ADT showed lower REMS-derived BMD at the lumbar spine (0.885 ± 0.08 vs. 0.945 ± 0.11 g/cm²; p = 0.007), corresponding to a 6.3% difference. Femoral neck BMD was also lower in the PCa group (0.691 ± 0.08 vs. 0.715 ± 0.10 g/cm²; p = 0.01), corresponding to a 3.4% difference.

Conclusions

These findings are consistent with the known skeletal effects of ADT and support the potential role of REMS as a radiation-free tool for identifying reduced axial BMD in men with PCa undergoing ADT. Longitudinal monitoring assessments are ongoing to clarify the temporal relationship between ADT exposure and progressive bone loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBone DensityAndrogen AntagonistsHumansMaleCross-Sectional StudiesProspective StudiesAgedUltrasonographyFemur NeckMiddle AgedLumbar VertebraeCase-Control Studies

Stichwörter der Autor:innen

ADTPCaProstate cancerREMSRadiofrequency Echographic Multi SpectrometryUltrasound

Substanzen

Androgen Antagonists

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Viale L. Pinto 1, Foggia, 71121, Italy.
  • Radiology Unit, Mount Sinai Hospital, 600 University Ave, Toronto, ON, M5G 1X5, Canada.
  • School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, London WC2R 2LS, London, UK.
  • Radiology Unit, "Dimiccoli" Hospital, Viale Ippocrate 15, Barletta, 76121, BT, Italy.
  • Unit of Urology, L. Bonomo Hospital, ASL BAT, Viale Istria 1, BT, 76123, Andria, Italy.
  • Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Viale L. Pinto 1, Foggia, 71121, Italy. giuseppe.guglielmi@unifg.it.

Förderung

  • Università di Foggia

Zitieren

APA

Montatore, M., Guglielmi, R., Isaac, A., Capasso, M. G., Corvasce, A., Masino, F., & Guglielmi, G. (2026). Radiofrequency Echographic Multi-Spectrometry for bone health assessment in prostate cancer patients receiving Androgen deprivation therapy: A prospective comparative observational study. Aging Clinical and Experimental Research, 38(1). https://doi.org/10.1007/s40520-026-03467-4

Vancouver

Montatore M, Guglielmi R, Isaac A, Capasso MG, Corvasce A, Masino F, et al. Radiofrequency Echographic Multi-Spectrometry for bone health assessment in prostate cancer patients receiving Androgen deprivation therapy: A prospective comparative observational study. Aging Clinical and Experimental Research. 2026;38(1). doi:10.1007/s40520-026-03467-4

BibTeX
@article{Montatore2026,
  author = {Montatore, Manuela and Guglielmi, Riccardo and Isaac, Amanda and Capasso, Maria Grazia and Corvasce, Antonio and Masino, Federica and Guglielmi, Giuseppe},
  title = {Radiofrequency Echographic Multi-Spectrometry for bone health assessment in prostate cancer patients receiving Androgen deprivation therapy: A prospective comparative observational study},
  journal = {Aging Clinical and Experimental Research},
  year = {2026},
  volume = {38},
  number = {1},
  doi = {10.1007/s40520-026-03467-4}
}
Kostenlos starten →